Coherus Oncology, Inc. (CHRS) Presents at UBS Virtual Oncology Day Transcript

Presentation Operator Welcome to the UBS Virtual Event. David Dai, you may begin. Xiaochuan DaiUBS Investment Bank, Research Division Great. Thank you, operator. Hi, everyone. I'm David Dai, I'm a biotech analyst here at UBS. Thanks for joining our inaugural Virtual Oncology day today. We continue our session with Coherus. It's our great pleasure to welcome Dennis Lanfear, Chief Executive Officer; Theresa Lavallee, Chief Development and Scientific Officer; and Rosh Dias, Chief Medical Officer. Thank you f ...